Showing 2 posts of 2 posts found.


Retrophin announces positive Phase II results, Shkreli claims credit

September 8, 2016
Research and Development Phase II, Retrophin, Shkreli, rare kidney disease

Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …


KaloBios cuts ties with former CEO Martin Shkreli, outlines ‘maniacal’ turnaround plan

August 30, 2016
Research and Development, Sales and Marketing Daraprim, KaloBios, Martin Shkreli, Retrophin, benznidazole, turnaround

Two months after small drugmaker KaloBios returns from bankruptcy, controversial industry figure Martin Shkreli is no longer a stakeholder in …

Latest content